Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.
about
Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trialMolecular basis of intrinsic macrolide resistance in the Mycobacterium tuberculosis complexTelithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data.Antibiotic resistance versus small molecules, the chemical evolution.Management of community-associated methicillin-resistant Staphylococcus aureus infections in children.Genetic diversity of the tet(M) gene in tetracycline-resistant clonal lineages of Streptococcus pneumoniae.Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain.Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux PumpsA novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenesDifferent erythromycin resistance mechanisms in group C and group G streptococciInduction of ermAMR from a clinical strain of Enterococcus faecalis by 16-membered-ring macrolide antibioticsEffect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.Recent progress in novel macrolides, quinolones, and 2-pyridones to overcome bacterial resistance.Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants.Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway.Changing molecular epidemiology of group B streptococcus in KoreaUse of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and childrenPrevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in Southern Taiwan.Unusual occurrence of M type 77, antibiotic-resistant group A streptococci in southern Sweden.Differentiation of resistance phenotypes among erythromycin-resistant Pneumococci.Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network.Molecular detection of antimicrobial resistanceErythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci.In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteriaPhenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strainsPrevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.The macrolide-lincosamide-streptogramin B resistance determinant from Clostridium difficile 630 contains two erm(B) genes.Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureusResistance to macrolides in Streptococcus pyogenes in France in pediatric patients.Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South AfricaMechanisms of macrolide resistance in clinical group B streptococci isolated in France.Prevalence of macrolide resistance genes in clinical isolates of the Streptococcus anginosus ("S. milleri") group.Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter studyIn vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
P2860
Q28476520-26A5E966-8FFF-447E-A702-B2A200C5135CQ28487335-F9FA479D-F675-4FCF-A6F8-07B9E0BE79CFQ30806051-599CF727-089A-48B7-B7FF-E7BB596DEA5CQ30811036-0DB81341-A27E-481D-B315-1AA34CC43BF9Q33264579-65B4769D-A7C7-46B1-87CA-50BFA6687D1BQ33593820-42B0DD68-D4AC-4628-A3FA-61758D9D699FQ33604557-9AC20922-FAA8-4FE0-871B-8C6FEB98C3C6Q33659230-F2594EE1-F391-48C0-918F-0708B221CC15Q33689490-2D6DF7F9-5006-4F60-A5D1-5232E50D8916Q33693662-68487568-A69A-4D7B-ACE1-45B769118260Q33740414-F1FFF0F5-59D7-4724-AA82-DD7468D56568Q33748441-057674DF-936B-49EC-9273-6B7BEF01071BQ33771929-606752D7-7BEA-4DD7-89E1-DB43B6C84D42Q33785512-04355BD9-47A3-466C-81E6-D8E2C5BE0498Q33858998-4C65E9D3-8211-428F-A606-5AFC55C6C546Q33879685-B84D81E2-2715-4597-BF92-F8D7B01E5DC7Q33966765-93FDB028-9D07-46DB-A16E-4642DE8C8FC9Q33968036-6627EE69-BA5C-4176-BD60-5C1203B9442EQ33971210-D30403CF-D577-4D61-B5B9-6851A01501BFQ33971827-E71B4C09-B7AA-436A-9D9D-78104E1001C2Q33972906-AC5ECC8E-C4E8-4C36-BDEF-CD5AB326DE1BQ33975793-9A850E80-5DA4-4200-ABD2-34473787C04AQ33975850-7050D13C-8D98-4BA2-9394-241B920BD3E0Q33976201-718966B7-1372-4F46-A168-8170ACDB85F9Q33976715-ADD0ACF2-DC91-47B7-AAC0-E4E073EEA297Q33977386-53284E1F-0EF3-49DB-B124-986B89CEDCF2Q33977572-1445137C-FF1E-4DF3-B14D-F552F4B5596EQ33977860-53CAFC82-7A1B-4C9F-8A98-2A455119B2B3Q33977893-250B1237-6B8C-4CDB-A52F-0D3D9052E7A2Q33978060-C3AB008E-28F8-47FF-AB45-73540A814075Q33978773-37E22349-DF49-4B2D-AB72-880B26C620C1Q33979371-B277FD43-9E69-461C-A4F9-083CA1E177B3Q33979617-95A767D3-6408-490C-A642-EA040B148148Q33981528-BC8A26EF-F1D7-4AA9-81A9-F8CCAADC5D32Q33981950-D99A0471-1B6E-4F50-B638-8196FABAF32AQ33982164-7724068C-C873-4586-9C5A-8FDCBB7CFE84Q33982390-56AC6B93-0835-4C4E-B7BE-7248A689B017Q33982805-9A8979B8-E77A-4829-A1ED-781A29A870CCQ33982834-6EDC6DC8-89D6-4AB8-A806-1B54377CFD76Q33983762-BF8813C5-F05F-4905-80A4-B4E9A3892FB7
P2860
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bacterial resistance to macrol ...... iotics by target modification.
@en
Bacterial resistance to macrol ...... iotics by target modification.
@nl
type
label
Bacterial resistance to macrol ...... iotics by target modification.
@en
Bacterial resistance to macrol ...... iotics by target modification.
@nl
prefLabel
Bacterial resistance to macrol ...... iotics by target modification.
@en
Bacterial resistance to macrol ...... iotics by target modification.
@nl
P2860
P356
P1476
Bacterial resistance to macrol ...... iotics by target modification.
@en
P2093
Courvalin P
Leclercq R
P2860
P304
P356
10.1128/AAC.35.7.1267
P407
P577
1991-07-01T00:00:00Z